Analysis of resistance to pyrimethamine/sulphadoxine of isolates of Plasmodium falciparum from Eastern Thailand. 1986

G E Childs, and A Sabchareon, and T Chongsuphajaisiddi, and T Wimonwattrawatee, and B Ratharatorn, and H K Webster

The in vitro susceptibility of five field isolates of Plasmodium falciparum from the region of the Thai-Kampuchean border to pyrimethamine, sulphadoxine, and their combination, was determined using a microtitre test system and media deficient in p-aminobenzoic acid and folic acid. Two-fold serial dilutions of pyrimethamine ranging from concentrations of 8.0 to 0.125 microM and sulphadoxine ranging from 800 to 50 microM were evaluated for antimalarial activity. Viability was based on the maturation of the ring stages to normally-appearing schizonts. Tested singly the parasites had an average ID90 of 3.82 microM for pyrimethamine and greater than 800 microM for sulphadoxine. Analysis of the drugs interaction showed maximum potentiation at approximately 0.8 microM of pyrimethamine and 80 microM of sulphadoxine. These results suggest that resistance to Fansidar is due to the resistance to both components. Although there was a potentiating effect it was probably not sufficient enough for the drugs to be effective in vivo. This may, in part, explain the reduction in clinical cures with the sulphadoxine-pyrimethamine combination in eastern Thailand.

UI MeSH Term Description Entries
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D011739 Pyrimethamine One of the FOLIC ACID ANTAGONISTS that is used as an antimalarial or with a sulfonamide to treat toxoplasmosis. Chloridin,Daraprim,Malocide,Tindurine
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013413 Sulfadoxine A long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary tract, and malarial infections. Sulformethoxine,Sulforthomidine,Fanasil,Ro 4-4393,Sulformetoxine,Sulphormetoxin,Sulphorthodimethoxine,Ro 4 4393,Ro 44393
D013424 Sulfanilamides Compounds based on 4-aminobenzenesulfonamide. The '-anil-' part of the name refers to aniline. Sulphanilamides
D013785 Thailand Formerly known as Siam, this is a Southeast Asian nation at the center of the Indochina peninsula. Bangkok is the capital city. Kingdom of Thailand,Siam

Related Publications

G E Childs, and A Sabchareon, and T Chongsuphajaisiddi, and T Wimonwattrawatee, and B Ratharatorn, and H K Webster
October 2006, Malaria journal,
G E Childs, and A Sabchareon, and T Chongsuphajaisiddi, and T Wimonwattrawatee, and B Ratharatorn, and H K Webster
November 2020, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases,
G E Childs, and A Sabchareon, and T Chongsuphajaisiddi, and T Wimonwattrawatee, and B Ratharatorn, and H K Webster
April 1987, The Medical journal of Australia,
G E Childs, and A Sabchareon, and T Chongsuphajaisiddi, and T Wimonwattrawatee, and B Ratharatorn, and H K Webster
July 2015, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases,
G E Childs, and A Sabchareon, and T Chongsuphajaisiddi, and T Wimonwattrawatee, and B Ratharatorn, and H K Webster
January 2015, Journal of postgraduate medicine,
G E Childs, and A Sabchareon, and T Chongsuphajaisiddi, and T Wimonwattrawatee, and B Ratharatorn, and H K Webster
November 1984, Antimicrobial agents and chemotherapy,
G E Childs, and A Sabchareon, and T Chongsuphajaisiddi, and T Wimonwattrawatee, and B Ratharatorn, and H K Webster
January 1972, Transactions of the Royal Society of Tropical Medicine and Hygiene,
G E Childs, and A Sabchareon, and T Chongsuphajaisiddi, and T Wimonwattrawatee, and B Ratharatorn, and H K Webster
May 2014, The American journal of tropical medicine and hygiene,
G E Childs, and A Sabchareon, and T Chongsuphajaisiddi, and T Wimonwattrawatee, and B Ratharatorn, and H K Webster
March 2007, Antimicrobial agents and chemotherapy,
G E Childs, and A Sabchareon, and T Chongsuphajaisiddi, and T Wimonwattrawatee, and B Ratharatorn, and H K Webster
August 1998, Tropical medicine & international health : TM & IH,
Copied contents to your clipboard!